BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 139936)

  • 21. Intrarenal distribution and ATPase inhibiting activity of ouabain in dogs.
    Saito H; Nishida H; Monma Y; Tanabe T
    Jpn J Pharmacol; 1976 Apr; 26(2):171-7. PubMed ID: 133262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The nature of the transport adenosine triphosphatase-digitalis complex. VIII. The relationship between in vivo-formed (3-H-ouabain-Na+, K+-adenosine triphosphatase) complex and ouabain-induced positive inotropism.
    Allen JC; Entman ML; Schwartz A
    J Pharmacol Exp Ther; 1975 Jan; 192(1):105-12. PubMed ID: 123584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between Na+, K+-ATPase inhibition and cardiac glycoside-induced arrhythmia in dogs.
    Zavecz JH; Dutta S
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(1):91-8. PubMed ID: 140324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The distribution of microsomal (Na+, K+)-ATPase in the rat heart and the effects of induced right ventricular hypertrophy and feeding with digitalis, sodium, and potassium.
    Gibson K; Harris P
    Cardiovasc Res; 1970 Jan; 4(1):6-13. PubMed ID: 4244565
    [No Abstract]   [Full Text] [Related]  

  • 25. Enhancement of cardiac actions of ouabain and its binding to Na+, K+-adenosine triphosphatase by increased sodium influx in isolated guinea-pig heart.
    Temma K; Akera T
    J Pharmacol Exp Ther; 1982 Nov; 223(2):490-6. PubMed ID: 6290640
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cardiac glycoside receptor: its properties and its correlation to nucleotide binding sites, phosphointermediate, and (Na++K+)-ATPase activity.
    Erdmann E; Patzelt R; Schoner W
    Recent Adv Stud Cardiac Struct Metab; 1976; 9():329-35. PubMed ID: 130661
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Localization and characterization of binding sites with high affinity for [3H]ouabain in cerebral cortex of rabbit brain using quantitative autoradiography.
    Antonelli MC; Baskin DG; Garland M; Stahl WL
    J Neurochem; 1989 Jan; 52(1):193-200. PubMed ID: 2535710
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The insect brain (Na+ + K+)-ATPase. Binding of ouabain in the hawk moth, Manduca sexta.
    Rubin AL; Clark AF; Stahl WL
    Biochim Biophys Acta; 1981 Dec; 649(2):202-10. PubMed ID: 6274399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypertrophied rat heart. New Na+, K+-ATPase-ouabain interactions in sarcolemma vesicles.
    Charlemagne D; Mansier P; Preteseille M; Swynghedauw B; Lelievre LG
    Eur Heart J; 1984 Dec; 5 Suppl F():315-21. PubMed ID: 6099807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of vanadium on different adenosinetriphosphatases and binding of 3H-labeled ouabain and calcium-45 to rat brain synaptosomes.
    Mishra SK; Osborn RL; Desaiah D
    J Toxicol Environ Health; 1981 Sep; 8(3):449-61. PubMed ID: 6212691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations in renal Na+K+ATPase activity and [3H]ouabain binding in Goldblatt hypertensive rabbits.
    Akabane S; Natsume T; Matsushima Y; Deguchi F; Kuramochi M; Ito K
    J Hypertens; 1985 Oct; 3(5):469-74. PubMed ID: 2415578
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcium-ouabain interaction in a "microsomal" membrane fraction containing Na+, K+-ATPase activity and calcium binding activity.
    Entman ML; Allen JC; Schwartz A
    J Mol Cell Cardiol; 1972 Aug; 4(4):435-41. PubMed ID: 4262253
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on (Na+ + K+)-activated ATPase. XXXVIII. A 100 000 molecular weight protein as the low-energy phosphorylated intermediate of the enzyme.
    Schuurmans Stekhoven FM; van Heeswijk MP; de Pont JJ; Bonting SL
    Biochim Biophys Acta; 1976 Jan; 422(1):210-24. PubMed ID: 2305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability of [3H]ouabain binding to the (Na+ + K+)-ATPase solubilized with C12E8.
    Inaba M; Maede Y
    Biochim Biophys Acta; 1985 Aug; 818(2):267-70. PubMed ID: 2992592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human myocardial Na,K-ATPase concentration in heart failure.
    Bundgaard H; Kjeldsen K
    Mol Cell Biochem; 1996; 163-164():277-83. PubMed ID: 8974067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reductions of myocardial Na-K-ATPase activity and ouabain binding sites in heart failure: prevention by nadolol.
    Fan TH; Frantz RP; Elam H; Sakamoto S; Imai N; Liang CS
    Am J Physiol; 1993 Dec; 265(6 Pt 2):H2086-93. PubMed ID: 8285248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for the binding of beta-adrenoceptor blockers to microsomal Na+/K+-ATPase in guinea pig heart preparations.
    Almotrefi AA; Basco C; Moorji A; Dzimiri N
    Can J Physiol Pharmacol; 2001 Jan; 79(1):8-12. PubMed ID: 11201505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Na-K pump site density and ouabain binding affinity in cultured chick heart cells.
    Lobaugh LA; Lieberman M
    Am J Physiol; 1987 Nov; 253(5 Pt 1):C731-43. PubMed ID: 2446503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ouabain binding to phospholipid-dependent adenosine triphosphatase.
    Goodman SL; Wheeler KP
    Biochem J; 1978 Feb; 169(2):313-20. PubMed ID: 147079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ouabain-binding and phosphorylation of (Na+ + K+) ATPase treated with N-ethylmaleimide or oligomycin.
    Hegyvary C
    Biochim Biophys Acta; 1976 Feb; 422(2):365-79. PubMed ID: 129164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.